Leveljump Healthcare Corp. entered into an agreement with its executive officers to purchase 5,000,000 units at an issue price of CAD 1 per unit for the gross proceeds of CAD 5,000,000 on February 28, 2023. Each unit consist of one common share at an issue price of CAD 0.10 per Common Share and one 8% cumulative redeemable convertible Class A Series 1 preferred share at an issue price of CAD 0.90 per preferred share. Each Preferred Share is non-voting, carries a cumulative annual dividend of 8% payable quarterly,along with a top up dividend of 25% of the portion of LevelJump's EBITDA that is above CAD 2,000,000 per year, divided by the then outstanding Preferred Shares. The Preferred Shares are redeemable on the fifth anniversary after issuance at a price of CAD 1.00 per Preferred Share together with all accrued and unpaid dividends. The Preferred Shares are also convertible,prior to being redeemed or called, into common shares of the Company at a price of CAD 0.40 per Common Share. Subject to applicable law and to certain exceptions, LevelJump may, at any time prior to the Redemption Date, purchase for cancellation all or any number of the Preferred Shares outstanding from time to time at any price in the open market if they are listed or posted for trading on a stock exchange or by tender available to all of holders of Preferred Shares or by private agreement or otherwise. To date, the Company has sold 114,000 units in a prior offering and has commitments for a further 1,130,000 units. The Company will be offering the remaining 3,756,000 units at this time on approval from the TSXV exchange.

On March 31, 2023, the dividend is CAD 0.02 per share and is payable to the shareholders of record of the A-1 Preferred Shares.